{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:11:08Z","timestamp":1792228268487,"version":"4.4.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088591","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T21:57:19Z","timestamp":1392155839000},"page":"e88591","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":157,"title":["Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Jan","family":"Jessen Krut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Mellberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central nervous system viral invasion and inflammation during acute HIV infection","volume":"206","author":"V Valcour","year":"2012","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2334-5-98","article-title":"Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment","volume":"5","author":"SS Spudich","year":"2005","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","article-title":"Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection","volume":"21","author":"M Gisslen","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bmj.299.6703.819","article-title":"Declining incidence of AIDS dementia complex after introduction of zidovudine treatment","volume":"299","author":"P Portegies","year":"1989","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/cid\/ciq041","article-title":"Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study","volume":"52","author":"FX Lescure","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","article-title":"Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy","volume":"73","author":"LA Cysique","year":"2009","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00126334-200405010-00003","article-title":"Highly active antiretroviral therapy improves neurocognitive functioning","volume":"36","author":"KR Robertson","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/00002030-199910010-00011","article-title":"Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment","volume":"13","author":"V Tozzi","year":"1999","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"A Antinori","year":"2007","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"RK Heaton","year":"2010","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia","volume":"24","author":"S Simioni","year":"2010","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2334-11-356","article-title":"The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?","volume":"11","author":"M Gisslen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11481-006-9035-1","article-title":"Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers","volume":"2","author":"M Gisslen","year":"2007","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","article-title":"CSF neurofilament protein (NFL) \u2013 a marker of active HIV-related neurodegeneration","volume":"254","author":"S Abdulle","year":"2007","journal-title":"J Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/518043","article-title":"Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex","volume":"195","author":"M Gisslen","year":"2007","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1073\/pnas.84.10.3472","article-title":"Neurofilament gene expression: a major determinant of axonal caliber","volume":"84","author":"PN Hoffman","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"N Norgren","year":"2003","journal-title":"Brain Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"LE Rosengren","year":"1996","journal-title":"J Neurochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.52.5.1090","article-title":"Neurofilament protein levels in CSF are increased in dementia","volume":"52","author":"LE Rosengren","year":"1999","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1212\/01.wnl.0000277635.05973.55","article-title":"Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection","volume":"69","author":"A Mellgren","year":"2007","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","article-title":"Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection","volume":"7","author":"L Hagberg","year":"2010","journal-title":"AIDS Res Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"G Tibbling","year":"1977","journal-title":"Scand J Clin Lab Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/clinids\/17.4.802","article-title":"1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults","volume":"17","author":"KG Castro","year":"1993","journal-title":"Clinical Infectious Diseases"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.41.6.778","article-title":"Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection","volume":"41","author":"RS Janssen","year":"1991","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/QAD.0b013e32834a40cd","article-title":"CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy","volume":"25","author":"RJ Ellis","year":"2011","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13550280600915339","article-title":"Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection\u2013The Hawaii Aging with HIV Cohort","volume":"12","author":"V Valcour","year":"2006","journal-title":"J Neurovirol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"RK Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2377-13-54","article-title":"Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia","volume":"13","author":"M Landqvist Waldo","year":"2013","journal-title":"BMC Neurol"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Scherling CS, Hall T, Berisha F, Klepac K, Karydas A, <etal>et al<\/etal>.. (2013) CSF neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol.","DOI":"10.1002\/ana.24052"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1750-3639.1991.tb00656.x","article-title":"Neuropathology of human immunodeficiency virus infection","volume":"1","author":"H Budka","year":"1991","journal-title":"Brain Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/WNL.42.9.1707","article-title":"The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study","volume":"42","author":"JC McArthur","year":"1992","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410340307","article-title":"Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier","volume":"34","author":"C Power","year":"1993","journal-title":"Ann Neurol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts","volume":"10","author":"LA Cysique","year":"2004","journal-title":"J Neurovirol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T09:51:15Z","timestamp":1648288275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088591"}},"subtitle":[],"editor":[{"given":"Yolande","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088591","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}